Cargando…
Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591435/ https://www.ncbi.nlm.nih.gov/pubmed/34782756 http://dx.doi.org/10.1038/s41423-021-00795-5 |
| _version_ | 1784599233925480448 |
|---|---|
| author | Xiang, Tiandan Liang, Boyun Wang, Hua Quan, Xufeng He, Shengsong Zhou, Helong He, Yongwen Yang, Dongliang Wang, Baoju Zheng, Xin |
| author_facet | Xiang, Tiandan Liang, Boyun Wang, Hua Quan, Xufeng He, Shengsong Zhou, Helong He, Yongwen Yang, Dongliang Wang, Baoju Zheng, Xin |
| author_sort | Xiang, Tiandan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8591435 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85914352021-11-15 Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection Xiang, Tiandan Liang, Boyun Wang, Hua Quan, Xufeng He, Shengsong Zhou, Helong He, Yongwen Yang, Dongliang Wang, Baoju Zheng, Xin Cell Mol Immunol Correspondence Nature Publishing Group UK 2021-11-15 2021-12 /pmc/articles/PMC8591435/ /pubmed/34782756 http://dx.doi.org/10.1038/s41423-021-00795-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Xiang, Tiandan Liang, Boyun Wang, Hua Quan, Xufeng He, Shengsong Zhou, Helong He, Yongwen Yang, Dongliang Wang, Baoju Zheng, Xin Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title | Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title_full | Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title_fullStr | Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title_full_unstemmed | Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title_short | Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection |
| title_sort | safety and immunogenicity of a sars-cov-2 inactivated vaccine in patients with chronic hepatitis b virus infection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591435/ https://www.ncbi.nlm.nih.gov/pubmed/34782756 http://dx.doi.org/10.1038/s41423-021-00795-5 |
| work_keys_str_mv | AT xiangtiandan safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT liangboyun safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT wanghua safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT quanxufeng safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT heshengsong safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT zhouhelong safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT heyongwen safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT yangdongliang safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT wangbaoju safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection AT zhengxin safetyandimmunogenicityofasarscov2inactivatedvaccineinpatientswithchronichepatitisbvirusinfection |